These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 35509752)

  • 1. Comparison of Clinical Characteristics and Outcome Between Vaccinated and Non-Vaccinated Patients of Covid-19 During the Delta Variant-Dominated Fourth Wave in a Tertiary Care Hospital in Karachi, Pakistan.
    Khan JA; Satti L; Bizanjo M; Ather NA
    Cureus; 2022 Apr; 14(4):e23726. PubMed ID: 35509752
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of Clinical Characteristics and Outcome of COVID-19 Patients Between the 4
    Khan JA; Khattak MI; Satti ML; Bazanjo M; Ather NA; Abbas R
    J Coll Physicians Surg Pak; 2023 Aug; 33(8):857-860. PubMed ID: 37553922
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the Disease Severity and Outcome of Vaccinated COVID-19 Patients with Unvaccinated Patients in a Specialized COVID-19 Facility: A Retrospective Cohort Study from Karachi, Pakistan.
    Sayeed MA; Shalim E; Farooqui F; Farman S; Khan M; Iqbal A; Ahmed I; Rajput AW; Razzaque A; Quraishy S
    Vaccines (Basel); 2023 Jun; 11(7):. PubMed ID: 37514994
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Postvaccination infections among staff of a tertiary care hospital after vaccination with severe acute respiratory syndrome coronavirus 2 vector and mRNA-based vaccines.
    Brunner-Ziegler S; Spath T; Kornek G; König F; Parschalk B; Schnetzinger M; Straßl RP; Savic R; Foit A; Resch H; Thalhammer F
    Clin Microbiol Infect; 2022 Apr; 28(4):596-601. PubMed ID: 34915073
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Severity of COVID 19 Pneumonia in Vaccinated vs. Non-vaccinated Patients in the Second Wave: An Experience From a Tertiary Care Center in India.
    Bajpai J; Kant S; Verma A; Patwa AK; Atam V; Chaudhary SC; Pandey A
    Cureus; 2022 May; 14(5):e25378. PubMed ID: 35774652
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical Characteristics and Outcome of Patients With Severe COVID-19 Pneumonia at a Public Sector Hospital in Karachi, Pakistan.
    Baqi S; Naz A; Sayeed MA; Khan S; Ismail H; Kumar V; Somjimal H; Aneela J; Imtiaz S; Aftab S
    Cureus; 2021 Feb; 13(2):e13107. PubMed ID: 33728127
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical Characteristics and Outcomes Among Adults Hospitalized with Laboratory-Confirmed SARS-CoV-2 Infection During Periods of B.1.617.2 (Delta) and B.1.1.529 (Omicron) Variant Predominance - One Hospital, California, July 15-September 23, 2021, and December 21, 2021-January 27, 2022.
    Modes ME; Directo MP; Melgar M; Johnson LR; Yang H; Chaudhary P; Bartolini S; Kho N; Noble PW; Isonaka S; Chen P
    MMWR Morb Mortal Wkly Rep; 2022 Feb; 71(6):217-223. PubMed ID: 35143466
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical Characteristics and Risk Factors for Mortality in Critical Coronavirus Disease 2019 Patients 50 Years of Age or Younger During the Delta Wave: Comparison With Patients > 50 Years in Korea.
    Shi HJ; Nham E; Kim B; Joo EJ; Cheong HS; Hong SH; Hyun M; Kim HA; Jang S; Rhee JY; Kim J; Kim S; Cho HK; Wi YM; Cheon S; Kim YS; Lim S; Seok H; Jung SI; Eom JS; Peck KR
    J Korean Med Sci; 2022 Jun; 37(22):e175. PubMed ID: 35668685
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SARS-CoV-2 Infections and Hospitalizations Among Persons Aged ≥16 Years, by Vaccination Status - Los Angeles County, California, May 1-July 25, 2021.
    Griffin JB; Haddix M; Danza P; Fisher R; Koo TH; Traub E; Gounder P; Jarashow C; Balter S
    MMWR Morb Mortal Wkly Rep; 2021 Aug; 70(34):1170-1176. PubMed ID: 34437525
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transmission and Infectious SARS-CoV-2 Shedding Kinetics in Vaccinated and Unvaccinated Individuals.
    Jung J; Kim JY; Park H; Park S; Lim JS; Lim SY; Bae S; Lim YJ; Kim EO; Kim J; Park MS; Kim SH
    JAMA Netw Open; 2022 May; 5(5):e2213606. PubMed ID: 35608859
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Impact of SARS-CoV-2 Primary Vaccination in a Cohort of Patients Hospitalized for Acute COVID-19 during Delta Variant Predominance.
    Stupica D; Collinet-Adler S; Kejžar N; Jagodic Z; Poljak M; Nahtigal Klevišar M
    J Clin Med; 2022 Feb; 11(5):. PubMed ID: 35268282
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Confirmed Delta Variant COVID-19 Infection at A Single Centre Tertiary Hospital: A Case Series.
    Nasution SA; Muhadi M; Tenda ED
    Acta Med Indones; 2022 Apr; 54(2):299-302. PubMed ID: 35818659
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effectiveness of mRNA BNT162b2 COVID-19 vaccine against SARS-CoV-2 Delta variant among elderly residents from a long-term care facility, South of France, May 2021.
    Sánchez Ruiz MA; Adonias G; Robaglia-Schlupp A; Rapilly F; Chabert M; Ramalli L; Reilhes O; Bruel C; Malfait P; Chaud P
    Eur Rev Med Pharmacol Sci; 2022 Apr; 26(7):2586-2591. PubMed ID: 35442474
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical characteristics of COVID-19 in Osaka, Japan: Comparison of the first-third waves with the fourth wave.
    Kurahara Y; Kobayashi T; Shintani S; Matsuda Y; Tamiya A; Sugawara R; Arai T; Tachibana K; Okishio K; Matsui H; Tsuyuguchi K
    Respir Investig; 2021 Nov; 59(6):810-818. PubMed ID: 34565716
    [TBL] [Abstract][Full Text] [Related]  

  • 15. BCG revaccination of health workers in Brazil to improve innate immune responses against COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Junqueira-Kipnis AP; Dos Anjos LRB; Barbosa LCS; da Costa AC; Borges KCM; Cardoso ADRO; Ribeiro KM; Rosa SBA; Souza CC; das Neves RC; Saraiva G; da Silva SM; Silveira EA; Rabahi MF; Conte MB; Kipnis A
    Trials; 2020 Oct; 21(1):881. PubMed ID: 33106170
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Maternal Mortality with SARS-COV-2 during its 4th Wave in Pakistan: The Vaccine Paradox and Pregnancy.
    Aslam J; Masroor M; Mehmood QU; Arshad M; Jabeen S; Mushtaq MA
    J Coll Physicians Surg Pak; 2022 Jan; 32(1):119-121. PubMed ID: 34983164
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vaccine efficacy against severe COVID-19 in relation to delta variant (B.1.617.2) and time since second dose in patients in Scotland (REACT-SCOT): a case-control study.
    McKeigue PM; McAllister DA; Hutchinson SJ; Robertson C; Stockton D; Colhoun HM
    Lancet Respir Med; 2022 Jun; 10(6):566-572. PubMed ID: 35227416
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomized, double-blind, placebo-controlled phase III clinical trial to evaluate the efficacy and safety of SARS-CoV-2 vaccine (inactivated, Vero cell): a structured summary of a study protocol for a randomised controlled trial.
    Akova M; Unal S
    Trials; 2021 Apr; 22(1):276. PubMed ID: 33849629
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Description of Symptoms Caused by the Infection of the SARS-CoV-2 B.1.621 (Mu) Variant in Patients With Complete CoronaVac Vaccination Scheme: First Case Report From Santiago of Chile.
    Barrera-Avalos C; Luraschi R; Acuña-Castillo C; Vidal M; Mella-Torres A; Inostroza-Molina A; Vera R; Vargas S; Hernández I; Perez C; Vallejos-Vidal E; Valdés D; Imarai M; Reyes-López FE; Sandino AM
    Front Public Health; 2022; 10():797569. PubMed ID: 35387187
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of Vaccination on Markers of Severity among Elderly Covid-19 Patients-A Retrospective Comparative Analysis.
    Saha L; Thakuria R; Swami A
    J Assoc Physicians India; 2022 Apr; 70(4):11-12. PubMed ID: 35443504
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.